Sintx Technologies entered into a Letter Agreement with MedTech Ceramics to resolve abeyance shares and replace an existing warrant. The company will release 255,267 common shares and issue a pre-funded warrant for 251,987 shares, both for no additional consideration. The prior September 2025 warrant for 760,881 shares will be canceled and replaced with a new warrant for 1,268,135 shares at $2.14, expiring five years from issuance. Sintx will file a resale registration for the new warrant shares within 45 days, aiming to streamline its capital structure and support stockholders' equity.
Agreement details:
- Agreement type: Letter Agreement for equity issuance and warrant replacement
- Counterparty: MedTech Ceramics
- Signed / Effective: Jun 29 2026 / Jun 29 2026
- Duration / Termination: At will
- Reason: Manage capital structure and improve stockholders' equity position
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.